Invention Grant
- Patent Title: Deuterated ibrutinib
-
Application No.: US15220642Application Date: 2016-07-27
-
Publication No.: US09777009B2Publication Date: 2017-10-03
- Inventor: Roger D. Tung , Adam J. Morgan
- Applicant: CONCERT PHARMACEUTICALS, INC.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/00 ; C07D487/04 ; C07B59/00
Abstract:
The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Public/Granted literature
- US20170015670A1 DEUTERATED IBRUTINIB Public/Granted day:2017-01-19
Information query
IPC分类:
